INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
BROOK JACKSON SPILLS THE BEANS ON LACK OF PFIZER OVERSIGHT

BROOK JACKSON SPILLS THE BEANS ON LACK OF PFIZER OVERSIGHT

Indisputable evidence that Pfizer was asleep at the 'injections' wheel.

Hedley Rees's avatar
Hedley Rees
Feb 18, 2022
∙ Paid
4

Share this post

INSIDE PHARMA
INSIDE PHARMA
BROOK JACKSON SPILLS THE BEANS ON LACK OF PFIZER OVERSIGHT
Share

BROOK JOINS VENTAVIA

On September 7, 2020, Brook Jackson began her employment with Ventavia Research Group (“Ventavia”) as a Regional Director.

Ventavia is not owned by Pfizer. Pfizer had offloaded the clinical trial work onto what is known as a Contract Research Organisation (CRO).

CROs work on a fee-for-service basis, and they have grown like topsy over the last 30 or so years, covering all aspects of work relating to preclinical testing and trials in humans.

CROs quality of work varies greatly, and unfortunately for Brook, she had been recruited into one at the bottom of the pile.

HORRIFIC DOESN’T EVEN COME CLOSE

Describing what Brook discovered at Ventavia as ‘horrific’ doesn’t come close to it—the violations and malpractice was

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share